In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials ...

Immunai already has strategic agreements with 30 pharmaceuticals companies, most of them involving much smaller financial ...

As part of the collaboration, drugmaker will use Immunai's AI model of the immune system and machine learning for clinical ...

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...